Interestingly, today Reach Pharmaceuticals has announced that the TGA has granted dexrazoxane Orphan Designation in Australia.
Reach have 6 months now I believe to submit their registration dossier to the TGA for evaluation.
Whilst it doesn't have a direct impact on RAC I do find it interesting that the noise around cardio-oncology and cardioprotection is starting to be amplified globally. RAC couldn't be better positioned to become a global leader in this space. Looking forward to seeing how the team plan to execute on cardio-oncology in the new strategy.
- Forums
- ASX - By Stock
- RAC
- Industry news
Industry news, page-1492
-
- There are more pages in this discussion • 326 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.86 |
Change
-0.015(0.80%) |
Mkt cap ! $316.8M |
Open | High | Low | Value | Volume |
$1.88 | $1.88 | $1.79 | $163.0K | 89.00K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 34299 | $1.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.86 | 3635 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 34027 | 1.840 |
1 | 3000 | 1.810 |
1 | 1231 | 1.790 |
1 | 8557 | 1.770 |
4 | 10695 | 1.750 |
Price($) | Vol. | No. |
---|---|---|
1.860 | 3635 | 1 |
1.875 | 198 | 1 |
1.895 | 3000 | 1 |
1.900 | 33 | 1 |
1.940 | 5148 | 2 |
Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |